blood thinner
| 4 min read
New potential drug candidates made entirely of synthetic DNA may outperform current available blood clot treatments and avoid the adverse effects.
Page 1 of 1 - 1 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Learn the key characteristics that determine whether an immunoassay generates accurate and reproducible data.
Explore how antibody accessibility and custom development strategies can influence the pace and success of translational research.
Learn the key differences between chemical and enzymatic approaches to synthetic DNA production and their implications for modern research.
